Primary tabs
Export 15 results:
Filters: Author is Pieter Pannus
Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients,
, Kidney International Reports, Jan-03-2024, Volume 9, Issue 3, Number 648, (2024)
Persistent defect in SARS-CoV-2 humoral and cellular immunity in lung transplant recipients.,
, J Heart Lung Transplant, 2024 Aug 10, (2024)
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients.,
, Cancer Cell, 2022 Apr 11, Volume 40, Issue 4, (2022)
Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19.,
, JCI Insight, 2022 Apr 05, Volume 7, Issue 9, (2022)
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients.,
, Clin Cancer Res, 2022 Nov 07, (2022)
Hybrid immunity to SARS-CoV-2 in kidney transplant recipients and hemodialysis patients.,
, Am J Transplant, 2022 Mar, Volume 22, Issue 3, (2022)
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.,
, Front Immunol, 2022, Volume 13, (2022)
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.,
, Front Immunol, 2022, Volume 13, (2022)
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial,
, PLOS Global Public Health, Dec-20-2022, Volume 2, Issue 12, (2022)
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.,
, NPJ Vaccines, 2022 Mar 08, Volume 7, Issue 1, (2022)
Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2.,
, J Clin Virol, 2021 09, Volume 142, (2021)
Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes.,
, Clin Infect Dis, 2021 Dec 03, (2021)
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients.,
, J Hematol Oncol, 2021 Oct 24, Volume 14, Issue 1, (2021)
The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.,
, Arch Public Health, 2021 Nov 11, Volume 79, Issue 1, (2021)
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.,
, ESMO Open, 2021 Oct, Volume 6, Issue 5, (2021)